Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.
type: Dataset
description: International audience
issued: 2026-05-07T21:07:40.487009
language: en
modified: 2026-05-07T21:07:40.487014
contact point: Organization
  fn: CCSD
keyword: infoeu-reposemanticsarticle
keyword: journal-articles
keyword: monoclonal-antibodies
keyword: pancreatic-cancer
keyword: rtk
keyword: sdvcanlife-sciences-q-biocancer
keyword: targeted-therapy
landing page: 0950-9232

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.
type: Distribution
format: HTML
issued: 2026-05-07T21:07:40.505014
modified: 2026-05-07T21:07:40.476086
access URL: https://inserm.hal.science/inserm-00916587

test_moissonnage_selune
type: Agent